BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim WJ, Lim TW, Park PJ, Choi SB, Kim WB. Clinicopathological Differences in T2 Gallbladder Cancer According to Tumor Location. Cancer Control 2020;27:1073274820915514. [PMID: 32233806 DOI: 10.1177/1073274820915514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Alrawashdeh W, Kamarajah SK, Gujjuri RR, Cambridge WA, Shrikhande SV, Wei AC, Abu Hilal M, White SA, Pandanaboyana S. Systematic review and meta-analysis of survival outcomes in T2a and T2b gallbladder cancers. HPB (Oxford) 2022;24:789-96. [PMID: 35042673 DOI: 10.1016/j.hpb.2021.12.019] [Reference Citation Analysis]
2 Zhu J, Wu Y, Xiao W, Li Y. Survival Predictors of Resectable Gallbladder Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. The American Surgeon. [DOI: 10.1177/00031348221074238] [Reference Citation Analysis]
3 Khan SM, Emile SH, Choudhry MS, Sumbal R. Tumor location and concurrent liver resection, impact survival in T2 gallbladder cancer: a meta-analysis of the literature. Updates Surg 2021;73:1717-26. [PMID: 34426958 DOI: 10.1007/s13304-021-01150-z] [Reference Citation Analysis]
4 Yasukawa K, Shimizu A, Motoyama H, Kubota K, Notake T, Sugenoya S, Hosoda K, Hayashi H, Kobayashi R, Soejima Y. Applicability of sentinel lymph node oriented treatment strategy for gallbladder cancer. PLoS One 2021;16:e0247079. [PMID: 33577620 DOI: 10.1371/journal.pone.0247079] [Reference Citation Analysis]
5 García P, Lamarca A, Díaz J, Carrera E, Roa JC, On Behalf Of The European-Latin American Escalon Consortium. Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients. Cancers (Basel) 2020;12:E3670. [PMID: 33297469 DOI: 10.3390/cancers12123670] [Reference Citation Analysis]